We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MG:NYSEMistras Group Inc Analysis

Data as of 2026-05-23 - not real-time

$17.28

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mistras Group delivered a solid Q1 performance, with revenue rising 4.6% year‑over‑year to $731 million and GAAP net income turning positive at $2.4 million, translating to earnings per diluted share of $0.07 that beat expectations by 75%. Management highlighted margin improvement, adding 120 basis points to gross margin and expanding operating margin to just under 3%, while reaffirming 2026 guidance of $730‑$750 million revenue and $91‑$93 million adjusted EBITDA.
On the technical side, the stock trades at $17.28, sitting just below the 20‑day SMA of $17.91 but above the 50‑day SMA of $16.74, indicating a bullish trend supported by a 20‑day SMA crossover. RSI is neutral at 48.7, MACD is currently bearish, and the price is above the identified support of $15.54 with resistance near $19.56. Volatility is elevated at roughly 36% over the past 30 days and beta exceeds 1.2, suggesting heightened price swings, yet the Fear & Greed Index reads “Extreme Greed,” implying strong market appetite. Valuation metrics show a trailing P/E of 24.7 versus an industry average of 29.7 and a forward P/E of 13.9, pointing to a relative discount and an upside potential of about 21.5%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Q1 earnings beat and margin expansion
  • Price near short‑term support with bullish SMA alignment
  • MACD bearish divergence adding caution

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Revenue growth and favorable forward P/E of 13.9
  • Reaffirmed guidance with upside of ~21.5%
  • Diversified exposure to aerospace, defense, and renewable energy

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High leverage (debt‑to‑equity >100%)
  • Cyclical exposure to industrial services
  • Strong cash flow generation but limited dividend yield

Key Metrics & Analysis

Financial Health

Revenue Growth4.60%
Profit Margin3.06%
P/E Ratio24.7
ROE10.38%
ROA6.33%
Debt/Equity107.46
P/B Ratio2.4
Op. Cash Flow$30.1M
Free Cash Flow$2.9M
Industry P/E29.7

Technical Analysis

TrendBullish
RSI48.7
Support$15.54
Resistance$19.56
MA 20$17.91
MA 50$16.74
MA 200$13.05
MACDBearish
VolumeStable
Fear & Greed Index91.61

Valuation

Target Price$21.00
Upside/Downside21.53%
GradeUndervalued
TypeBlend

Risk Assessment

Beta1.25
Volatility35.96%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.